Filana Therapeutics, Inc. (FLNA)
0.9309
-0.03
(-3.53%)
USD |
NASDAQ |
Oct 02, 16:00
0.9506
+0.02
(+2.12%)
After-Hours: 20:00
Filana Therapeutics Max Drawdown (5Y) : 99.34% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.34% |
| August 31, 2026 | 99.34% |
| July 31, 2026 | 99.34% |
| June 30, 2026 | 99.14% |
| May 31, 2026 | 99.13% |
| April 30, 2026 | 99.12% |
| March 31, 2026 | 99.12% |
| February 28, 2026 | 99.12% |
| January 31, 2026 | 99.12% |
| December 31, 2025 | 99.12% |
| November 30, 2025 | 99.12% |
| October 31, 2025 | 99.12% |
| September 30, 2025 | 99.12% |
| August 31, 2025 | 99.12% |
| July 31, 2025 | 99.12% |
| June 30, 2025 | 99.12% |
| May 31, 2025 | 99.12% |
| April 30, 2025 | 99.12% |
| March 31, 2025 | 98.89% |
| February 28, 2025 | 98.32% |
| January 31, 2025 | 98.31% |
| December 31, 2024 | 98.31% |
| November 30, 2024 | 97.17% |
| October 31, 2024 | 93.81% |
| September 30, 2024 | 96.21% |
| Date | Value |
|---|---|
| August 31, 2024 | 96.21% |
| July 31, 2024 | 96.68% |
| June 30, 2024 | 96.88% |
| May 31, 2024 | 97.50% |
| April 30, 2024 | 97.60% |
| March 31, 2024 | 97.60% |
| February 29, 2024 | 97.60% |
| January 31, 2024 | 97.60% |
| December 31, 2023 | 98.00% |
| November 30, 2023 | 98.20% |
| October 31, 2023 | 98.20% |
| September 30, 2023 | 98.20% |
| August 31, 2023 | 98.20% |
| July 31, 2023 | 98.20% |
| June 30, 2023 | 98.20% |
| May 31, 2023 | 98.20% |
| April 30, 2023 | 98.20% |
| March 31, 2023 | 98.20% |
| February 28, 2023 | 98.20% |
| January 31, 2023 | 98.20% |
| December 31, 2022 | 98.20% |
| November 30, 2022 | 98.20% |
| October 31, 2022 | 98.20% |
| September 30, 2022 | 98.20% |
| August 31, 2022 | 98.20% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| CorMedix, Inc. | 84.47% |
| Eloxx Pharmaceuticals, Inc. | 100.0% |
| BioStem Technologies, Inc. | 94.21% |
| Wave Life Sciences, Inc. | 97.77% |
| Axsome Therapeutics, Inc. | 79.54% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -54.49 |
| Beta (5Y) | -0.6546 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 112.7% |
| Historical Sharpe Ratio (5Y) | -0.5415 |
| Historical Sortino (5Y) | -1.032 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.54% |